SCHEMBL30310377

SCHEMBL30310377

[2H]NC(=O)c1cc2c(OC)cccc2[nH]1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FLT3 P36888 2/20 0.61
▸ HRH4 Q9H3N8 1/20 0.56
▸ KMT2A Q03164 4/20 0.54
▸ MEN1 O00255 3/20 0.54
▸ RCE1 Q9Y256 1/20 0.54
▸ RAB9A P51151 3/20 0.53
▸ POLB P06746 2/20 0.53
▸ NPC1 O15118 2/20 0.53
▸ IDO1 P14902 1/20 0.53
▸ MTNR1A P48039 4/20 0.50
▸ MTNR1B P49286 4/20 0.50
▸ KDM4E B2RXH2 3/20 0.50
▸ MAPT P10636 3/20 0.50
▸ LMNA P02545 1/20 0.50
▸ PKM P14618 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ HDAC3 O15379 2/20 0.49
▸ HDAC1 Q13547 2/20 0.49
▸ HDAC4 P56524 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24447653 0.90 FLT3 (0.66) FLT3HRH4KMT2AMEN1RCE1
SCHEMBL29394458 0.90 FLT3 (0.66) FLT3HRH4KMT2AMEN1RCE1
SCHEMBL7979026 0.82 FLT3 (0.68) FLT3HRH4KMT2AMEN1RCE1
SCHEMBL913914 0.82 FLT3 (0.68) FLT3HRH4KMT2AMEN1RCE1
SCHEMBL29414307 0.82 FLT3 (0.68) FLT3HRH4KMT2AMEN1RCE1
SCHEMBL217459 0.81 FLT3 (0.66) FLT3HRH4KMT2AMEN1RCE1
SCHEMBL24113092 0.81 FLT3 (0.66) FLT3HRH4KMT2AMEN1RCE1
SCHEMBL30310403 0.81 FLT3 (0.66) FLT3HRH4KMT2AMEN1RCE1
SCHEMBL23835764 0.78 FLT3 (0.63) FLT3HRH4KMT2AMEN1RCE1
SCHEMBL24019713 0.78 IDO1 (0.64) FLT3HRH4KMT2AMEN1RCE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4161902-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. (US) 2023-04-12 — — EP disclosed
Send feedback